“Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s94. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1064.